IL6 and neoplasm: Other research has reported similar results, such as the activation of cytotoxic T cells (TC cells), improved DC maturation, the increased production of IL-8 and other cytokines (TNF-α, IL-1, IL-4, IL-6, IFN-γ) through the activation of T cell receptors (TCRs), enhanced major histocompatibility complex (MHC) class I expression by tumor cells, the inhibition of tumor growth, and the in vitro reduction of tumor growth factor-β (TGF-β) [16,17,18].